About Epstein-Barr virus-associated infectious mononucleosis

Article

Although the Epstein-Barr virus causes most illnesses presenting as mononucleosis, clinicians should be able to recognize and consider alternate differential possibilities.

Recent Videos
Geetika Kennady, MD, FAAP
Jillian Cotter, MD
Jesse Hinckley, MD, PhD
Validating digital stethoscope for pediatric breath sounds, with Jennifer Nestor, MD
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Sensory play for children with autism, with Joshua Feder, MD
Stephanie Chao, MD
Feasibility of ambulatory blood pressure monitoring in primary care | Carissa Baker-Smith, MD, MPH
Tina Tan, MD
Camille Walker CPNP-PC, MSN, CPNP Sacheen D. Harris MSN, CPNP-PC
Related Content
INF108 to prevent necrotizing enterocolitis receives FDA designations | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

INF108 to prevent necrotizing enterocolitis receives FDA designations

Joshua Fitch, Senior Editor
May 8th 2025
Article

NEC is a life-threatening condition marked by the death of intestinal tissue, which impacts preterm infants.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
A new model for caring for children in foster care | AdobeStock_559786219

A new model for caring for children in foster care

Lucy Z. Garbus, MSN, CPNP
May 8th 2025
Article

Be the change you want to see.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Neffy 1 mg now available for anaphylaxis is pediatric patients | Image Credit: © MQ-Illustrations - © MQ-Illustrations - stock.adobe.com.

Neffy 1 mg now available for anaphylaxis in children aged 4 years and up

Joshua Fitch, Senior Editor
May 7th 2025
Article

Prescriptions for the epinephrine nasal spray are now available for patients aged 4 years and up who weigh 33 to < 66 lbs.

Suzanne Hollander, MS, RD, LDN, Senior Clinical Nutrition Specialist, Boston Children's Hospital | Image credit: Boston Children's

PKU and sepiapterin data with Suzanne Hollander, MS, RD, LDN

Suzanne Hollander, MS, RD, LDN
May 7th 2025
Article

A review of the clinical potential of PTC Therapeutics' sepiapterin as a novel treatment for phenylketonuria (PKU).

© 2025 MJH Life Sciences

All rights reserved.